Centrum Kardiologiczne Pro Corde Sp. z o.o.
- Address
- Ul. Nowowiejska 64-66/1a, 50-315 Wroclaw, Poland
Nutritional and Metabolic Diseases (C18)
The site focuses on nutritional and metabolic diseases, specifically targeting adults at high cardiovascular risk without prior myocardial infarction or stroke, and elderly patients experiencing frailty with iron deficiency alongside cardiovascular disease. Current trials are assessing the impact of a novel lipid‑lowering agent, evolocumab, and comparing intravenous iron supplementation to oral iron to improve physical performance and quality of life.
- Evaluation of a PCSK9 inhibitor to reduce coronary events in high‑risk patients receiving optimized lipid therapy
- Comparison of intravenous ferric carboxymaltose versus oral ferrous sulphate and placebo to improve physical performance in frail, iron‑deficient elderly with cardiovascular disease
Centrum Kardiologiczne Pro Corde in Wrocław, Poland, is conducting two investigator‑led studies with a team of two researchers, exploring advanced lipid management and iron repletion strategies for cardiovascular health.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Wroclaw Medical University1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum Kardiologiczne Pro Corde Sp. z o.o.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Evolocumab on Cardiovascular Outcomes in High-Risk Patients Without Prior Myocardial Infarction or Stroke | Amgen Inc. | Phase III | Not Recruiting | May 2019 | Jul 2025 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dried Ferrous Sulfate | 1 | Unknown | 2026-07-30 | 2026-07-30 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.